Title: Measuring performance in biopharmaceutical product development process: What counts?

Authors: Laura Heinonen

Addresses: Faculty of Life Sciences and Business, Turku University of Applied Sciences, Lemminkäisenkatu, 30 20520 Turku, Finland

Abstract: Biopharmaceutical industry is a science-based industry with exceptionally long, expensive and complicated product development processes. Measuring performance in the industry is not a simple task, as the conventional indicators of performance can rarely be used in this context. Young biopharmaceuticals can be defined as cash-burning non-profit companies, which are in continuous need of external finance. This paper describes the performance metrics in different stages of the biopharmaceutical product development process and evaluates the importance of these metrics in attracting investors. The empirical study focuses on Finnish biopharmaceutical companies. The data consists of both interviews and secondary sources.

Keywords: biotechnology; biopharmaceuticals; product development; performance measurement; venture capital investment; Finland.

DOI: 10.1504/IJTIP.2009.029375

International Journal of Technology Intelligence and Planning, 2009 Vol.5 No.4, pp.357 - 372

Published online: 28 Nov 2009 *

Full-text access for editors Full-text access for subscribers Purchase this article Comment on this article